Absci (ABSI) Return on Sales [ROS] (2020 - 2026)
Absci (ABSI) recorded Return on Sales [ROS] of -10741.51% in Q2 2026, down 5447.58 percentage points from -5293.93% a year earlier but up 3605.47 percentage points from the prior quarter.
Powered by 
Analysis
Absci (ABSI) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
On a TTM basis, Absci's Return on Sales [ROS] came in at -8084.50% as of Jun 30, 2026, down 5237.93 percentage points year-over-year; for FY2025, it came in at -4297.04%, down 1895.45 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for five straight years, with a five-year change of -4018.77 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -2401.59% in FY2024 (-381.39 pp), -2020.20% in FY2023 (-162.71 pp), -1857.49% in FY2022 (-284.13 pp) and -1573.36% in FY2021 (-1295.09 pp).
- Quarterly Return on Sales [ROS] has ranged from -14346.98% in Q1 2026 to -1180.54% in Q3 2022 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has declined for five consecutive quarters, with an average year-over-year change of -2833.65 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 2841.94 percentage points in Q4 2024, against a drop of 11995.07 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -14346.98% (Q1 2026), -4775.54% (Q4 2025) and -7977.25% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Absci | 1.90 Bn | 1.28 Bn | - | -10,741.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,741.51% |
| Mar 31, 2026 | -14,346.98% |
| Dec 31, 2025 | -4,775.54% |
| Sep 30, 2025 | -7,977.25% |
| Jun 30, 2025 | -5,293.93% |
| Mar 31, 2025 | -2,351.91% |
| Dec 31, 2024 | -4,477.29% |
| Sep 30, 2024 | -1,698.71% |
| Jun 30, 2024 | -2,104.02% |
| Mar 31, 2024 | -2,616.70% |
| Dec 31, 2023 | -7,319.23% |
| Sep 30, 2023 | -3,132.12% |
| Jun 30, 2023 | -1,276.74% |
| Mar 31, 2023 | -1,929.47% |
| Dec 31, 2022 | -1,354.72% |
| Sep 30, 2022 | -1,180.54% |
| Jun 30, 2022 | -2,882.93% |
| Mar 31, 2022 | -3,516.85% |
| Dec 31, 2021 | -1,808.26% |
| Sep 30, 2021 | -1,373.75% |
API Access
Absci Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();